RecruitingNCT04220970

Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry

Sponsor

The Lymphoma Academic Research Organisation

Enrollment

150 participants

Start Date

Jun 7, 2017

Study Type

OBSERVATIONAL

Conditions

Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)

Summary

Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant. Because of the low incidence of this disease and the peculiar histological subtype, French authorities, in accordance with the recommendations of an expert group, recommended the implementation of a BIA-ALCL case registry, in connection with a national Multidisciplinary meeting (Réunion de Concertation Pluridisciplinaire nationale de recours- RCP). This registry is opened in France and in Belgium

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a registry (data collection study) for patients who develop a rare type of lymphoma — a cancer of the immune system — that is linked to breast implants, known as BIA-ALCL. The goal is to collect information about these patients to better understand the disease. **You may be eligible if...** - You are an adult (18 or older) - You have been diagnosed with anaplastic large cell lymphoma (a type of immune system cancer) that is associated with breast implants **You may NOT be eligible if...** - You do not have a diagnosis of breast implant-associated anaplastic large cell lymphoma - You are under 18 years of age Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBIA-ALCL

Observational : no intervention

Locations(31)

A. Z. Sint-Jan Brugge-Oostende AV

Bruges, Belgium

Clinique Universitaire Saint LUC

Brussels, Belgium

Cliniques Universitaires de Bruxelles - Hôpital Erasme

Brussels, Belgium

Institut Jules Bordet

Brussels, Belgium

Universitair Ziekenhuis Brussel

Brussels, Belgium

Universitair Ziekenhuis Antwerpen

Edegem, Belgium

Universitair Ziekenhuis Gent

Ghent, Belgium

U.Z. Leuven - Campus Gasthuisberg

Leuven, Belgium

CHU de Liège -Domaine Sart Tilman

Liège, Belgium

CHU UCL Namur - Site Godinne

Yvoir, Belgium

CH d Avignon - Hopital Henri Duffaut

Avignon, France

Institut Bergonié

Bordeaux, France

CHRU de Brest - Hôpital Morvan

Brest, France

Hopital Louis Pasteur

Colmar, France

APHP - Hopital Henri Mondor

Créteil, France

CHU de Dijon - Hôpital le Bocage

Dijon, France

Centre Médical la Roseraie

Lille, France

Centre Léon Bérard

Lyon, France

Institut Paoli Calmettes

Marseille, France

CH Saint-Eloi

Montpellier, France

CHU de Nantes - Hôtel Dieu

Nantes, France

Hôpital Cochin

Paris, France

CH de Pau

Pau, France

CH de Perpigan

Perpignan, France

Centre Hospitalier Lyon Sud

Pierre-Bénite, France

Chu de Reims - Hopital Robert Debre

Reims, France

Centre Henri Becquerel

Rouen, France

Centre Rene Hugenin

Saint-Cloud, France

CH de Saint Malo

St-Malo, France

CHRU de Strasbourg

Strasbourg, France

Institut Universitaire du Cancer - Oncopole Toulouse (IUCT-O)

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04220970